High concentrated probiotics improve inflammatory bowel diseases better than commercial concentration of probiotics

Journal of Food and Drug Analysis

Volumn 20, Issue SUPPL.1, 2012, Pages 292-295

  Kim, Eun Hee ^a   Hong, Hua ^a   Hong, Kyung Sook ^a   Choi, Ki Seok ^a   Han, Young Min ^a   Kangwan, Napapan ^a   Cho, Young Chae ^b   Hahm, Ki Baik ^a  

^a Gachon University College of Medicine   (South Korea)

^b AmBio Co Ltd   (South Korea)

Author keywords

"Amanlac" probiotics; Dextran sodium sulfate; Inflammatory bowel diseases

Indexed keywords

AMANLAC; CYCLOOXYGENASE 2; DEXTRAN SULFATE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; MATRIX METALLOPROTEINASE; PROBIOTIC AGENT; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; COLITIS; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE RELEASE; DRUG EFFICACY; ENTERITIS; HOMEOSTASIS; INTESTINE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; SCORING SYSTEM;

MUS;

EID: 84863679693     PISSN: 10219498     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (8)

1. Neish, A. S. 2009. Reviews in basic and clinical gastroenterology. Gastroenterol. 136: 65-80.
2. Gareau, M. G. Sherman, P. M. and Walker, W. A. 2010. Probiotics and the gutmicrobiota in intestinal health and disease. Nat. Rev. Gastroenterol. Hepatol. 7: 503-514.
3. Sans, M. 2009. Probiotics for Inflammatory Bowel Disease: A Critical Appraisal. Dig. Dis. 27: 111-114.
4. Zhu, Y. Luo, T. M. Jobin, C. and Young, H. A. 2011. Gut microbiota and probiotics in colon tumorigenesis. Cancer Lett. 309: 119-127.
5. Schultz, M. Scholmerich, J. and Rath, H. C. 2003. Rationale for probiotics and antibiotic treatment strategies in inflammatory bowel diseases. Dig. Dis. 21: 105-128. (Pubitemid 37323490)
6. Strober, W. and Fuss, I. J. 2011 Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterol. 140: 1756-1767.
7. Surh, Y. J. and Kundu, J. K. 2007. Cancer preventive phytochemicals as speed breakers in inflammatory signaling involved in aberrant COX-2 expression. Curr. Cancer Drug Targets 7: 447-458. (Pubitemid 47196204)
8. Wirtz, S. Neufert, C., Weigmann, B. and Neurath, M. F. 2007. Chemically induced mouse models of intestinal inflammation. Nat. Protoc. 2: 541-546. (Pubitemid 47040018)